Oxford Nanopore Technologies (LON:ONT) Given New GBX 225 Price Target at Deutsche Bank Aktiengesellschaft

Oxford Nanopore Technologies (LON:ONT) had its price target upped by equities research analysts at Deutsche Bank Aktiengesellschaft from GBX 210 to GBX 225 in a note issued to investors on Thursday,Digital Look reports. The brokerage presently has a “buy” rating on the stock. Deutsche Bank Aktiengesellschaft’s price target would suggest a potential upside of 33.77% from the company’s previous close.

Several other analysts have also recently weighed in on ONT. Berenberg Bank reissued a “buy” rating and set a GBX 250 price objective on shares of Oxford Nanopore Technologies in a report on Monday, January 12th. Peel Hunt restated a “hold” rating and set a GBX 153 price objective on shares of Oxford Nanopore Technologies in a report on Friday, December 5th. Finally, Royal Bank Of Canada increased their target price on shares of Oxford Nanopore Technologies from GBX 280 to GBX 300 and gave the stock an “outperform” rating in a report on Wednesday. Four research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of GBX 233.60.

Oxford Nanopore Technologies Stock Up 4.5%

Shares of LON ONT opened at GBX 168.20 on Thursday. Oxford Nanopore Technologies has a 52-week low of GBX 88.60 and a 52-week high of GBX 224.80. The company has a debt-to-equity ratio of 8.07, a quick ratio of 6.01 and a current ratio of 4.45. The business has a fifty day moving average of GBX 134.29 and a two-hundred day moving average of GBX 155.96. The stock has a market cap of £1.62 billion, a PE ratio of -11.36 and a beta of 0.80.

About Oxford Nanopore Technologies

Oxford Nanopore Technologies’ goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer.